Fucose supplementation in leukocyte adhesion deficiency type II
- 1 June 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 95 (11) , 3641-3643
- https://doi.org/10.1182/blood.v95.11.3641
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Correction of Leukocyte Adhesion Deficiency Type II With Oral FucoseBlood, 1999
- A New Type of Carbohydrate-deficient Glycoprotein Syndrome Due to a Decreased Import of GDP-fucose into the GolgiJournal of Biological Chemistry, 1999
- Defective intracellular activity of GDP‐d‐mannose‐4,6‐dehydratase in leukocyte adhesion deficiency type II syndromeFEBS Letters, 1998
- Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.Journal of Clinical Investigation, 1998
- Recurrent Severe Infections Caused by a Novel Leukocyte Adhesion DeficiencyNew England Journal of Medicine, 1992
- Rapid, simple enzymatic assay of free L-fucose in serum and urine, and its use as a marker for cancer, cirrhosis, and gastric ulcersClinical Chemistry, 1990
- Gas chromatographic retention of carbohydrate trimethylsilyl ethersJournal of Chromatography A, 1989